Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics

Clinical Pharmacokinetics

Volumn 45, Issue 8, 2006, Pages 843-850

  Darwish, Mona ^a   Kirby, Mary ^a   Robertson Jr , Philmore ^a   Hellriegel, Edward ^a   Jiang, John G ^a  

^a CEPHALON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; NALTREXONE;

ADULT; ANALGESIA; APHTHOUS ULCER; AREA UNDER THE CURVE; ARTERIAL BLOOD; ARTERIAL CIRCULATION; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CHEEK MUCOSA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INJECTION SITE EDEMA; MALE; OPEN STUDY; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TABLET FORMULATION; TACHYCARDIA; VENOUS BLOOD; VENOUS CIRCULATION; VOMITING;

ADMINISTRATION, BUCCAL; ADULT; ANALGESICS, OPIOID; DRUG ADMINISTRATION SCHEDULE; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; TABLETS; THERAPEUTIC EQUIVALENCY;

EID: 33746799704     PISSN: 03125963     EISSN: 03125963     Source Type: Journal    
DOI: 10.2165/00003088-200645080-00006     Document Type: Article

References (10)

1. Bennett D, Burton A, Fishman S, et al. Consensus panel recommendations for the assessment and management of breakthrough pain. Part 2: management. Pharm Ther 2005; 30 (6): 354-61
2. Pather SI, Siebert JM, Hontz J, et al. Enhanced buccal delivery of fentanyl using the OraVescent drug delivery system. Drug Deliv Tech 2001; 1 (1): 54-7
3. Eichman JD, Robinson JR. Mechanistic studies on effervescent-induced permeability enhancement. Pharm Res 1998; 15 (6): 925-30
4. Eichman JD, Yassin AEB, Robinson JR. The influence of invivo carbonation on GI physiological processes and drug permeability. Eur J Pharm Biopharm 1997; 44: 33-8
5. Durfee S, Messina J, Khankari RK. Fentanyl effervescent buccal tablets: enhanced buccal absorption. Am J Drug Deliv 2006; 4 (1): 1-5
6. Hudson RJ, Thomson IR, Cannon JE, et al. Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery. Anesthesiology 1986; 64 (3): 334-8
7. Hug Jr CC, Murphy MR. Tissue redistribution of fentanyl and termination of its effects in rats. Anesthesiology 1981; 55 (4): 369-75
8. Boer F, Bovill JG, Burm AG, et al. Uptake of sufentanil, alfentanil and morphine in the lungs of patients about to undergo coronary artery surgery. Br J Anaesth 1992; 68 (4): 370-5
9. Chiou WL. The phenomenon and rationale of marked depen-dence of drug concentration on blood sampling site. Implica-tions in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I). Clin Pharmacokinet 1989; 17 (3): 175-99
10. Hill HF, Chapman CR, Saeger LS, et al. Steady-state infusions of opioids in human: II. Concentration-effect relationships and therapeutic margins. Pain 1990; 43 (1): 69-79